MedTrace Logo

Reminiscence Therapy in Individuals With Dementia

NCT06180694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-04-17

No results posted yet for this study

Summary

This research will be carried out with the aim of determining the effect of reminiscence therapy applied to individuals with dementia on cognitive functions, anxiety, depression and activities of daily living.

The research will be conducted with a pre-test post-test single group, quasi-experimental research design.

Conditions

Interventions

OTHER

Reminiscence therapy

Reminiscence therapies will be applied to individuals with dementia in 45-minute sessions once a week for 8 weeks.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Amasya University

    lead OTHER

Principal Investigators

  • Merve çayır yılmaz, asst. prof. · Amasya University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2024-10-20
Completion
2024-11-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180694 on ClinicalTrials.gov